HotSpot Therapeutics

HotSpot Therapeutics is targeting nature’s regulatory mechanisms to create allosteric medicines that exhibit high precision and potency.  HotSpot’s proprietary SpotFinderTM technology platform is the first and only technology platform to systematically identify and target “regulatory hotspots” – a unique family of allosteric sites used by nature to regulate protein function.  Using bespoke chemistry approaches, HotSpot is developing a pipeline of first-in-class medicines for treatment of serious autoimmune diseases, metabolic diseases, and cancer.

Headquarters Cambridge, MA
Website www.hotspotthera.com​
Twitter @hotspotthera
Pipeline Preclinical